EUVIMEDEUVIMED entdecken
Open Access

Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer

Zhen Wang, Qian Xie, Yu Luo, Chuan Li, Wenqiang Guan, Yanling Zhang, Jidong Miao

Oncology Research · 2026 · 34 (7) · 1-10

DOI: 10.32604/or.2026.079813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Zhen Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zigong Fourth People's Hospital, Ziliujing District, Zigong, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Programmed Cell Death 1 Receptor, Immune Checkpoint Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsHumansFemaleMaleAgedMiddle AgedRetrospective StudiesTreatment OutcomeNeoplasm StagingAged, 80 and overAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Advanced non-small cell lung cancerPD-1 inhibitorsimmune-related adverse eventsprognosissafety

Substanzen

Programmed Cell Death 1 ReceptorImmune Checkpoint InhibitorsPDCD1 protein, human

Autor:innen und Institutionen

  • Department of Oncology, Zigong Fourth People's Hospital, Ziliujing District, Zigong, China.
  • School of Education and Sports, Sichuan Vocational College of Health and Rehabilitation, Yantian District, Zigong, China.
  • Department of Critical Care, Qingdao Municipal Hospital, Shinan District, Qingdao, China.
  • Department of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao University, Shinan District, Qingdao, China.

Zitieren

APA

Wang, Z., Xie, Q., Luo, Y., Li, C., Guan, W., Zhang, Y., & Miao, J. (2026). Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer. Oncology Research, 34(7), 1-10. https://doi.org/10.32604/or.2026.079813

Vancouver

Wang Z, Xie Q, Luo Y, Li C, Guan W, Zhang Y, et al. Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer. Oncology Research. 2026;34(7):1-10. doi:10.32604/or.2026.079813

BibTeX
@article{Wang2026,
  author = {Wang, Zhen and Xie, Qian and Luo, Yu and Li, Chuan and Guan, Wenqiang and Zhang, Yanling and Miao, Jidong},
  title = {Factors Affecting the Efficacy and Safety of First-Line Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {7},
  pages = {1--10},
  doi = {10.32604/or.2026.079813}
}
Kostenlos starten →